Mental Health Weekly Digest
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Weekly Digest
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acute Bipolar Mania
Risperdal reduces acute bipolar mania symptoms as early as day 3 of treatment
June 28th, 2004
Results from a controlled, large-scale, clinical trial show that when Risperdal (risperidone) was used to treat patients with acute bipolar mania, a statistically significant reduction of symptoms as compared to placebo was observed as early as the third day of treatment. Moreover, patients in the 3-week study receiving Risperdal achieved significantly higher rates of remission as defined by a well-validated scale measuring manic symptoms. The findings appear in the June issue of The American Journal of Psychiatry. "Bipolar disorder can be devastating. Manic behavior can cause huge problems for the patient and his or her family. The ability to...
Source: Mental Health Weekly Digest (2004-06-28)
|
